GO:0006525 arginine metabolic process: Nitrogen Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006525 (arginine metabolic process) describes all chemical reactions and pathways involving arginine, a conditionally essential amino acid that integrates nitrogen disposal, polyamine synthesis, nitric oxide production, and protein methylation [2,8].
• Arginine is synthesized from citrulline via the urea cycle enzymes ASS1 and ASL, and is degraded by ARG1, ARG2, and NOS enzymes, making it a central node in nitrogen metabolism [2,8].
• Dysregulated arginine metabolism contributes to cancer, neuroblastoma, liver disease, and inflammatory disorders through polyamine and nitric oxide pathways [3,4,5,6].
• Arginine methylation of proteins such as FUS and RIPK1 modulates phase separation and cell death signaling, linking arginine metabolism to neurodegeneration and liver homeostasis [5,7].
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of arginine metabolic genes in disease [1,3,4].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to accelerate arginine metabolism research.
Description
Arginine metabolic process (GO:0006525) encompasses the chemical reactions and pathways involving arginine, a semi-essential amino acid that serves as a precursor for nitric oxide, polyamines, creatine, and agmatine, and as a substrate for protein arginine methylation [2,8]. This process is fundamental to nitrogen homeostasis, as arginine sits at the crossroads of the urea cycle, glutamine/glutamate metabolism, and the citrulline-arginine cycle [2,8]. Researchers study GO:0006525 because its dysregulation is implicated in a wide range of pathologies, from cancer and neuroblastoma to liver injury and sterile inflammation [3,4,5,6]. The metabolic fate of arginine is determined by the relative activities of arginases (ARG1, ARG2), nitric oxide synthases (NOS1, NOS2, NOS3), arginine decarboxylase (ADC), and arginine:glycine amidinotransferase (GATM), as well as by transport across membranes [2,8]. In addition, arginine availability influences post-translational modifications such as methylation of arginine residues in proteins like FUS and RIPK1, which can alter phase separation and cell survival [5,7]. Understanding the molecular players and regulatory mechanisms of arginine metabolic process is therefore critical for developing targeted therapies and for interpreting metabolic reprogramming in disease [2,3,4].
arginine metabolic process At A Glance
| GO ID | GO:0006525 |
|---|---|
| GO term | arginine metabolic process |
| Ontology | biological_process |
| Synonym | arginine metabolism |
| Definition | The chemical reactions and pathways involving arginine, 2-amino-5-(carbamimidamido)pentanoic acid. |
| Major function | Integration of nitrogen disposal, polyamine and nitric oxide synthesis, and protein arginine methylation. |
| Key enzymes | ASS1, ASL, ARG1, ARG2, NOS1/2/3, ADC, GATM, OTC, CPS1 |
| Compartment | Cytosol, mitochondria, and extracellular space (via transporters) |
| Related pathways | Urea cycle, citrulline-nitric oxide cycle, polyamine biosynthesis, creatine synthesis |
What Is GO:0006525?
GO:0006525, arginine metabolic process, is defined by the Gene Ontology as the chemical reactions and pathways involving arginine, 2-amino-5-(carbamimidamido)pentanoic acid. In practical terms, it includes the biosynthesis of arginine from citrulline, its catabolism to ornithine and urea, its conversion to nitric oxide and citrulline, its decarboxylation to agmatine, and its use in protein synthesis and methylation reactions [2,8].
Why Is arginine metabolic process Important in Cell Biology?
Arginine metabolic process is important because it governs the availability of arginine for diverse biosynthetic and signaling pathways that control cell proliferation, immune function, and stress responses [2,8]. Its dysregulation is a hallmark of many cancers, where altered arginine metabolism supports polyamine synthesis and ferroptosis evasion, and of neuroblastoma, where diet-enhanced polyamine depletion can reprogram tumor metabolism. Moreover, arginine methylation of key signaling proteins such as RIPK1 and FUS links this metabolic process to liver homeostasis and neurodegeneration [5,7]. Consequently, targeting arginine metabolic enzymes is a promising therapeutic strategy, and robust experimental models are needed to validate causal relationships [1,3,4].
• Arginine is a precursor for nitric oxide, a key vasodilator and immune effector molecule.
• Arginine is required for polyamine synthesis, which supports cell proliferation and is often upregulated in cancer [3,4].
• Arginine metabolism is essential for ammonia detoxification through the urea cycle [2,8].
• Arginine methylation regulates protein phase separation and signaling, impacting neurodegeneration.
• Arginine availability influences T cell function and inflammatory responses.
• Dysregulated arginine metabolism is implicated in liver diseases and metabolic disorders.
• Arginine metabolism is a target for cancer therapy, including ferroptosis induction.
• Microbial arginine metabolism is exploited for industrial amino acid production.
• Arginine metabolic enzymes serve as biomarkers and therapeutic targets in neuroblastoma.
• Understanding arginine metabolism aids in designing nutritional and pharmacological interventions.
What Happens During arginine metabolic process?
Arginine Biosynthesis from Citrulline
In simple terms: The body makes arginine from citrulline in two steps.
Arginine is synthesized from citrulline via the sequential action of argininosuccinate synthetase (ASS1) and argininosuccinate lyase (ASL). ASS1 condenses citrulline with aspartate to form argininosuccinate, which ASL then cleaves to release arginine and fumarate [2,8]. This pathway is particularly active in the kidney and is crucial for maintaining systemic arginine levels. In humans, arginine is conditionally essential, meaning that endogenous synthesis may be insufficient during periods of rapid growth or stress.
Arginine Catabolism via Arginases
In simple terms: Arginine is broken down to ornithine and urea.
Arginases (ARG1 and ARG2) hydrolyze arginine to ornithine and urea, thereby feeding the urea cycle and providing ornithine for polyamine synthesis [2,8]. ARG1 is predominantly cytosolic and highly expressed in the liver, while ARG2 is mitochondrial and found in various tissues. This catabolic step is a major determinant of arginine availability for other pathways and is often upregulated in cancers to support polyamine production.
Nitric Oxide Synthesis
In simple terms: Arginine is converted to nitric oxide and citrulline.
Nitric oxide synthases (NOS1, NOS2, NOS3) oxidize arginine to produce nitric oxide (NO) and citrulline [2,6]. NO is a signaling molecule involved in vasodilation, neurotransmission, and immune defense. The citrulline generated can be recycled back to arginine via the citrulline-NO cycle, linking NO production to arginine regeneration.
Polyamine Biosynthesis
In simple terms: Arginine is used to make polyamines that help cells grow.
Arginine is converted to agmatine by arginine decarboxylase (ADC) or to ornithine by arginases; ornithine is then decarboxylated by ODC1 to putrescine, which is further converted to spermidine and spermine [3,4]. Polyamines are essential for cell proliferation and are often elevated in cancer, where they can also influence ferroptosis sensitivity. Targeting polyamine synthesis via arginine metabolism is a potential therapeutic strategy in neuroblastoma.
Protein Arginine Methylation
In simple terms: Arginine residues in proteins can be modified to affect their function.
Protein arginine methyltransferases (PRMTs) transfer methyl groups from S-adenosylmethionine to arginine residues in target proteins, influencing protein-protein interactions, phase separation, and signaling [5,7]. For example, methylation of FUS modulates its phase separation and is implicated in neurodegeneration, while arginine methylation of RIPK1 is regulated by adenosine metabolic clearance and maintains liver homeostasis. This connects arginine metabolism to epigenetic and post-translational regulation.
Key Genes Involved in GO:0006525 arginine metabolic process
The following genes encode enzymes, transporters, and regulatory proteins that directly participate in or regulate arginine metabolic process (GO:0006525).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ASS1 | Argininosuccinate synthetase; catalyzes citrulline + aspartate to argininosuccinate | Deficiency causes citrullinemia; often downregulated in cancers |
| ASL | Argininosuccinate lyase; cleaves argininosuccinate to arginine and fumarate | Deficiency causes argininosuccinic aciduria; involved in NO recycling |
| ARG1 | Arginase 1; hydrolyzes arginine to ornithine and urea | Liver-specific; upregulated in hepatocellular carcinoma; target for cancer therapy [2,3] |
| ARG2 | Arginase 2; mitochondrial arginase | Implicated in vascular and immune regulation; potential cancer target |
| NOS1 | Neuronal nitric oxide synthase; produces NO from arginine | Roles in neurotransmission and smooth muscle relaxation |
| NOS2 | Inducible nitric oxide synthase; produces NO in immune responses | Key in inflammation and host defense |
| NOS3 | Endothelial nitric oxide synthase; produces NO for vasodilation | Cardiovascular function; regulated by arginine availability |
| ADC | Arginine decarboxylase; converts arginine to agmatine | Agmatine has neuromodulatory and analgesic effects |
| GATM | Glycine amidinotransferase; uses arginine to synthesize creatine | Creatine synthesis; mutations cause creatine deficiency syndromes |
| OTC | Ornithine transcarbamylase; part of urea cycle | Deficiency causes hyperammonemia; related to arginine metabolism |
| CPS1 | Carbamoyl phosphate synthetase 1; urea cycle enzyme | Deficiency causes hyperammonemia; links to arginine metabolism |
| SLC7A1 | Cationic amino acid transporter; imports arginine | Regulates intracellular arginine availability |
| SLC7A2 | Cationic amino acid transporter; imports arginine | Modulates NO synthesis and immune function |
| PRMT1 | Protein arginine methyltransferase 1 | Methylates histones and non-histone proteins; roles in cancer [5,7] |
| PRMT5 | Protein arginine methyltransferase 5 | Symmetric dimethylation; involved in splicing and cancer |
| ODC1 | Ornithine decarboxylase; converts ornithine to putrescine | Rate-limiting for polyamine synthesis; target in cancer [3,4] |
| AMD1 | Adenosylmethionine decarboxylase; supports polyamine synthesis | Linked to polyamine metabolism and ferroptosis |
| SMS | Spermine synthase; converts spermidine to spermine | Polyamine homeostasis; potential cancer target |
How Is arginine metabolic process Regulated?
Arginine metabolic process is regulated at multiple levels. Enzyme expression is controlled by transcription factors such as C/EBP and HIF-1α in response to stress and oxygen availability. Allosteric regulation of ASS1 and ASL by arginine and citrulline modulates flux through the urea cycle. Arginine availability itself regulates mTORC1 signaling, which controls cell growth and proliferation. Additionally, arginine methylation of proteins like RIPK1 is dynamically regulated by adenosine metabolic clearance, linking energy status to cell survival. Hormonal signals, such as insulin and glucagon, also influence arginase expression in the liver.
arginine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARG1 | Hepatocellular carcinoma; polyamine synthesis | ARG1 knockout hepatoma cell lines; xenograft models |
| ODC1 | Neuroblastoma; polyamine addiction | ODC1 knockout or overexpression in neuroblastoma cells; diet intervention |
| RIPK1 | Liver homeostasis; inflammation | RIPK1 methylation-deficient knock-in mice; liver injury models |
| FUS | Amyotrophic lateral sclerosis; neurodegeneration | FUS arginine methylation mutants in neuronal cells; phase separation assays |
| NOS2 | Inflammatory diseases; sterile inflammation | NOS2 knockout macrophages; microneedle-based delivery models |
Arginine Metabolism in Cancer
Many cancers reprogram arginine metabolism to support rapid proliferation. Upregulation of arginase and ODC1 increases polyamine synthesis, which promotes growth and can suppress ferroptosis, a form of cell death. Targeting polyamine-mediated ferroptosis amplification has been proposed as a therapeutic vulnerability. In neuroblastoma, diet-enhanced polyamine depletion can reprogram tumor metabolism and inhibit growth. These findings highlight arginine metabolic enzymes as potential targets for cancer therapy.
Arginine Metabolism in Liver Disease
The liver is a central site of arginine metabolism, expressing high levels of ARG1 and urea cycle enzymes. Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1, a process that prevents excessive cell death and inflammation. Disruption of this pathway may contribute to liver injury and metabolic disorders.
Arginine Metabolism in Neurodegeneration
Arginine methylation of proteins such as FUS modulates phase separation, and aberrant methylation is linked to neurodegeneration. FUS phase separation is influenced by arginine cation-π interactions and can be modulated by molecular chaperones, suggesting that arginine metabolism impacts protein aggregation diseases.
Arginine Metabolism in Inflammation
Arginine is a substrate for nitric oxide synthesis, which is critical for immune responses and inflammation. Microneedles loaded with nitric-oxide-driven nanomotors improve efferocytosis impairment and sterile inflammation by revitalizing macrophage energy metabolism, highlighting the role of arginine-NO pathway in resolving inflammation.
From arginine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ARG1 affect tumor growth? | ARG1 knockout cancer cell lines (e.g., HepG2) and xenografts |
| Does point mutation in ASS1 alter urea cycle flux? | ASS1 point-mutant knock-in cell lines; metabolic flux analysis |
| Does arginine methylation of RIPK1 regulate liver homeostasis? | RIPK1 methylation-site knock-in mice; liver injury models |
| Does overexpression of ODC1 enhance polyamine synthesis? | ODC1 overexpression in neuroblastoma cells; polyamine profiling |
| Does FUS arginine methylation affect phase separation? | FUS methylation-mutant knock-in neurons; imaging of condensates |
| Does NOS2 knockout impair macrophage efferocytosis? | NOS2 knockout macrophages; sterile inflammation models |
How to Study the arginine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Stable isotope tracing | Flux through arginine metabolic pathways | Quantifying urea cycle and polyamine synthesis |
| CRISPR knockout screens | Gene essentiality and resistance | Identifying vulnerabilities to arginine deprivation [3,4] |
| LC-MS/MS proteomics | Arginine methylation sites | Mapping PRMT substrates and signaling [5,7] |
| Fluorescence microscopy | Protein phase separation | Studying FUS condensates and methylation effects |
| Nitric oxide measurement | NO production | Assessing NOS activity in inflammation |
| Polyamine quantification | Levels of putrescine, spermidine, spermine | Evaluating polyamine pathway activity [3,4] |
| Enzyme activity assays | Arginase, NOS, ODC activity | Validating genetic perturbations |
| RNA-seq | Transcriptional changes | Global response to arginine metabolic perturbations |
Metabolic Flux Analysis
Stable isotope tracing with 13C- or 15N-labeled arginine or citrulline followed by mass spectrometry allows quantification of flux through arginine metabolic pathways, including urea cycle, polyamine synthesis, and NO production [2,3]. This method is essential for understanding how genetic perturbations alter metabolic rewiring.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate sensitivity to arginine deprivation or polyamine inhibition [3,4]. Such screens have revealed ODC1 and other polyamine pathway genes as vulnerabilities in neuroblastoma.
Proteomics and Methylation Analysis
Mass spectrometry-based proteomics can map arginine methylation sites on proteins like FUS and RIPK1, providing insights into how arginine metabolism influences post-translational modifications [5,7]. Antibodies specific for asymmetric or symmetric dimethylarginine are used in immunoblotting and immunofluorescence.
Live-Cell Imaging of Phase Separation
Fluorescence microscopy of fluorescently tagged FUS or other proteins can visualize phase-separated condensates and how arginine methylation or metabolic changes affect their dynamics. This approach links arginine metabolism to biomolecular condensate biology.
How CRISPR Can Be Used to Study GO:0006525 arginine metabolic process
Knockout
CRISPR knockout of arginine metabolic genes such as ARG1, ODC1, or NOS2 in cell lines and primary cells enables loss-of-function studies to determine their roles in proliferation, polyamine synthesis, and inflammation [3,4,6]. Knockout models are also used in xenograft studies to assess tumor growth.
Point Mutation
Point mutations can be introduced into genes like ASS1 or RIPK1 to mimic disease-associated variants or to abrogate specific post-translational modification sites (e.g., arginine-to-lysine substitutions) [2,5]. These models help dissect the contribution of individual residues to enzyme activity or protein function.
Knock-in
Knock-in of tagged or reporter alleles (e.g., GFP-ARG1) allows real-time visualization of protein localization and dynamics. Knock-in of methylation-deficient RIPK1 mutants can test the importance of arginine methylation in liver homeostasis.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like ODC1 or NOS2 can model gain-of-function states observed in cancer and inflammation [3,4,6]. Overexpression models are useful for testing therapeutic inhibitors.
How EDITGENE Supports arginine metabolic process Research
Researchers studying arginine metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as tumor growth, metabolic flux, or inflammatory signaling. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE specializes in providing these services to accelerate discovery in arginine metabolism research.
Contact EDITGENE today to design your custom CRISPR model for arginine metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ART4 Knockout HEK293 Cell Line | EDJ-KQ3428 | Human | 420 | Details Get a Quote |
| ARG2 Knockout HEK293 Cell Line | EDC09599 | Human | 384 | Details Get a Quote |
| ASL Knockout HEK293 Cell Line | EDJ-KQ3432 | Human | 435 | Details Get a Quote |
| ARG1 Knockout HEK293 Cell Line | EDJ-KQ4083 | Human | 383 | Details Get a Quote |
| DDAH1 Knockout HEK293 Cell Line | EDJ-KQ8075 | Human | 23576 | Details Get a Quote |
| SLC39A8 Knockout HEK293 Cell Line | EDJ-KQ15342 | Human | 64116 | Details Get a Quote |
| SLC39A8 Knockout A-549 Cell Line | EDJ-KQ17917 | Human | 64116 | Details Get a Quote |
| ARG2 Knockout A-549 Cell Line | EDJ-KQ25156 | Human | 384 | Details Get a Quote |
| ARG2 Knockout HeLa Cell Line | EDJ-KQ25157 | Human | 384 | Details Get a Quote |
| SLC39A8 Knockout HCT 116 Cell Line | EDJ-KQ46063 | Human | 64116 | Details Get a Quote |
| SLC39A8 Knockout HeLa Cell Line | EDJ-KQ46064 | Human | 64116 | Details Get a Quote |
| ARG2 Knockout HCT 116 Cell Line | EDJ-KQ23773 | Human | 384 | Details Get a Quote |
| ASL Knockout A-549 Cell Line | EDJ-KQ26490 | Human | 435 | Details Get a Quote |
| ASL Knockout HCT 116 Cell Line | EDJ-KQ26492 | Human | 435 | Details Get a Quote |
| ASL Knockout HeLa Cell Line | EDJ-KQ26493 | Human | 435 | Details Get a Quote |
Displaying Records 1 To 15 Of 31 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About arginine metabolic process
What is arginine metabolic process (GO:0006525)?
GO:0006525 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving arginine, 2-amino-5-(carbamimidamido)pentanoic acid. It includes arginine biosynthesis, catabolism, and its use in nitric oxide, polyamine, and creatine synthesis [2,8].
What genes are involved in arginine metabolic process?
Key genes include ASS1, ASL, ARG1, ARG2, NOS1, NOS2, NOS3, ADC, GATM, OTC, CPS1, SLC7A1, SLC7A2, PRMT1, PRMT5, ODC1, AMD1, and SMS [2,3,4,5,7].
How is arginine metabolized in the body?
Arginine is synthesized from citrulline by ASS1 and ASL, catabolized by arginases to ornithine and urea, converted to nitric oxide and citrulline by NOS enzymes, and used for polyamine and creatine synthesis [2,8].
What diseases are linked to arginine metabolism?
Dysregulated arginine metabolism is linked to cancer, neuroblastoma, liver disease, neurodegeneration, and inflammatory disorders [3,4,5,6,7].
Why is arginine important for cancer?
Arginine supports polyamine synthesis and nitric oxide production, which promote tumor growth and survival. Targeting arginine metabolic enzymes can induce ferroptosis and inhibit proliferation [3,4].
How does arginine methylation affect protein function?
Arginine methylation by PRMTs can alter protein-protein interactions, phase separation, and signaling. For example, FUS methylation affects its phase separation, and RIPK1 methylation is important for liver homeostasis [5,7].
What is the role of nitric oxide in arginine metabolism?
Nitric oxide synthases convert arginine to nitric oxide and citrulline. NO is a signaling molecule involved in vasodilation, neurotransmission, and immune defense.
How can I study arginine metabolic process in the lab?
Common methods include stable isotope tracing, CRISPR screens, proteomics for methylation, live-cell imaging of phase separation, and enzyme activity assays [2,3,4,5,7].
What CRISPR models are available for arginine metabolism research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes in arginine metabolic process [1,3,4].
What is the connection between arginine metabolism and ferroptosis?
Polyamine synthesis downstream of arginine metabolism can suppress ferroptosis, and targeting this pathway can amplify ferroptosis in cancer cells.
Conclusion
Arginine metabolic process (GO:0006525) is a central biological pathway that integrates nitrogen disposal, polyamine and nitric oxide synthesis, and protein arginine methylation. Its dysregulation contributes to cancer, neuroblastoma, liver disease, neurodegeneration, and inflammation, making it a rich area for therapeutic targeting [2,3,4,5,6,7]. Advances in CRISPR-based models and metabolic profiling are enabling researchers to dissect causal roles of individual genes and to identify new vulnerabilities. EDITGENE provides comprehensive CRISPR cell model and screening services to support these efforts and accelerate discoveries in arginine metabolism.
References
- 1. Jiang Y et al.. 2021. l-arginine production in Corynebacterium glutamicum: manipulation and optimization of the metabolic process.. Crit Rev Biotechnol 41(2):172-185 PMID: 33153325
- 2. Fung TS et al.. 2025. Arginine: at the crossroads of nitrogen metabolism.. EMBO J 44(5):1275-1293 PMID: 39920310
- 3. Bi G et al.. 2024. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.. Nat Commun 15(1):2461 PMID: 38504107
- 4. Cherkaoui S et al.. 2025. Reprogramming neuroblastoma by diet-enhanced polyamine depletion.. Nature 646(8085):707-715 PMID: 40993392
- 5. Liu R et al.. 2026. Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1.. J Exp Med 223(1) PMID: 41081715
- 6. Tan H et al.. 2025. Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism.. ACS Nano 19(9):9390-9411 PMID: 40025734
- 7. Qamar S et al.. 2018. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.. Cell 173(3):720-734.e15 PMID: 29677515
- 8. Brosnan ME et al.. 2004. Renal arginine metabolism.. J Nutr 134(10 Suppl):2791S-2795S; discussion 2796S-2797S PMID: 15465786
